To evaluate the performance of serum CCL18 in diagnosis of SCCHN patients, receiver operating characteristic (ROC) curve analysis was performed for SCCHN patients, precancerous lesions and healthy controls. This evidence concerns the gene CCL18 and head and neck squamous cell carcinoma.